Our data revealed that rosuvastatin protected NP cells from the inflammatory response by regulating the HMGB1/NF-κB pathway, and this finding suggested a potential therapeutic effect of rosuvastatin on IDD. Here, HMGB1 is linked to intervertebral disk degenerative disorder.